TOP NEWS: AstraZeneca's Bydureon BCise For Diabetes Gets European Okay
LONDON (Alliance News) - AstraZeneca PLC on Thursday said the European Commission has approved its Bydureon BCise device for type-2 diabetes as a new formulation.Bydureon BCise has been the Read More